Menu

• Ask a Health Expert about BLOOD FIBRINOGEN ABNORMAL
• Post Your Side Effect related to BLOOD FIBRINOGEN ABNORMAL
• BLOOD FIBRINOGEN ABNORMAL and FDA Warnings
• BLOOD FIBRINOGEN ABNORMAL in Patients Wiki
• Report BLOOD FIBRINOGEN ABNORMAL in Drug Side Effect Survey

BLOOD FIBRINOGEN ABNORMAL side effect

What is BLOOD FIBRINOGEN ABNORMAL ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Arixtra Side Effects Report #5492041-0
Physician from UNITED STATES reported ARIXTRA problem on Oct 18, 2007. Male patient, 66 years of age, weighting 231.5 lb, was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen abnormal, cerebral haemorrhage, metastases to meninges, platelet count abnormal, . ARIXTRA dosage: 5MG DAILY SQ. Patient recovered.

Arixtra Side Effects Report #5502985-9
ARIXTRA problem was reported by a Physician from UNITED STATES on Oct 29, 2007. Male patient, 66 years of age, weighting 231.5 lb, was diagnosed with thrombosis and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen abnormal, cardio-respiratory arrest, cerebral haemorrhage, facial palsy, hypoaesthesia, metastases to central nervous system, nuclear magnetic resonance imaging brain abnormal, platelet count decreased, . ARIXTRA dosage: unknown. Patient died on 10/25/2007.

Decitabine Side Effects Report #5506432-2
Physician from TURKEY reported DECITABINE problem on Oct 22, 2007. Female patient, 64 years of age, weighting 163.1 lb, was treated with DECITABINE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood fibrinogen abnormal, brain scan abnormal, caecitis, diarrhoea, disease progression, fibrin d dimer increased, haemoglobin decreased, haemorrhage intracranial, . DECITABINE dosage: 225 MG, INTRAVENOUS. Patient was hospitalized and became disabled. Patient died on 03/22/2007.

Kaletra Side Effects Report #5470277-2
KALETRA problem was reported by a Consumer or non-health professional from ISRAEL on Sept 17, 2007. Male patient, weighting 108.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time abnormal, blood fibrinogen abnormal, blood lactate dehydrogenase abnormal, burkitt's lymphoma, hepatic neoplasm malignant, hepatomegaly, pleural effusion, pneumonia bacterial, . KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, LAMIVUDINE. Patient was hospitalized. Patient recovered.


Kaletra Side Effects Report #5397228-3
Consumer or non-health professional from ISRAEL reported KALETRA problem on July 15, 2007. Male patient, weighting 108.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time abnormal, blood fibrinogen abnormal, blood lactate dehydrogenase abnormal, burkitt's lymphoma, hepatic neoplasm malignant, hepatomegaly, pleural effusion, pneumonia bacterial, . KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, LAMIVUDINE. Patient was hospitalized. Patient recovered.

Kaletra Side Effects Report #5397228-3
KALETRA problem was reported by a Consumer or non-health professional from ISRAEL on July 15, 2007. Male patient, weighting 108.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time abnormal, blood fibrinogen abnormal, blood lactate dehydrogenase abnormal, burkitt's lymphoma, hepatic neoplasm malignant, hepatomegaly, pleural effusion, pneumonia bacterial, . KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, LAMIVUDINE. Patient was hospitalized. Patient recovered.

Ethyol Side Effects Report #5281119-2
Consumer or non-health professional from FRANCE reported ETHYOL problem on Mar 08, 2007. Male patient, 54 years of age, was treated with ETHYOL. After drug was administered, patient experienced the following problems/side effects: bleeding time prolonged, blood fibrinogen abnormal, haemoglobin decreased, kaolin cephalin clotting time abnormal, lymphocyte count decreased, lymphopenia, neutrophil count decreased, stevens-johnson syndrome, . ETHYOL dosage: unknown. Patient was hospitalized. Patient recovered.